their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve

% 1,337 -1.0% Selling and distribution expenses 884 924 -4.3% 903 -2.1% Administrative expenses 438 338 29.6% 434 1.1% EBIT 1,098 973 12.9% 1,073 2.4% EBITDA 1,339 1,236 8.3% 1,342 -0.2% Profit for the

Baht appreciation, affected to production competitiveness that manufacturers made decision to shift production base or import materials from foreign. Similarly, private investment sector and employment

(Microsoft Word - MPIC - 4150514765052264 E) -Translation – MPIC 013/2018 August 8, 2018 Subject: Notification of the investment in the distribution company in Cambodia Attn: The President The Stock

22.6% 2,781 2,452 13.5% Selling and distribution expenses 989 846 16.9% 1,873 1,769 5.9% Administrative expenses 470 344 36.6% 908 682 33.1% EBIT 889 815 9.0% 1,987 1,788 11.1% EBITDA 1,121 1,077 4.1

from 79.01 Million Baht to 74.65 Million Baht or 5.52% due to cancellation of licensor distribution and manufacturing. This affects extensive project cannot apply tender as a results. 2. The Company’s

Company Limited and Phong-Sra Distribution Company Limited (Revise) 30/12/2021 13:23 Notification of the acquisition of assets in ordinary shares of Pongsara-Manufacturing Co., Ltd. and Pongsara

consistent increase in its retail channel sales; the main distribution channel, from the Company’s strategy to enlarge its customer base, and debuted the B20 Diesel product in tandem with a special price

Sustainability Issues on Valuation and Performance” for investment analysts and “Navigating the Future of Investing in the Time of Sustainability: A Paradigm Shift in the Roles of Investment Consultants?” for

100.00% 111.56 3.23% Distribution costs 140.16 4.05% 159.58 4.47% 19.42 13.86% Administrative expenses 88.53 2.56% 105.99 2.97% 17.45 19.72% Profit from operating activities 64.65 1.87% 69.66 1.95% 5.01